Tissue Diagnostics Market Size, Share | Trends Report 2032

Tissue Diagnostics Market Size - By Product (Consumables, Instruments), Technology (Immunohistochemistry (IHC), In-situ Hybridization (ISH), Special Staining, Digital Pathology, Management), Application (Breast Cancer, Prostate Cancer, Lung Cancer, Lymphoma, Gastric Cancer), End-use (Hospitals, Research Laboratories, Pharmaceutical Companies, CROs) – Global Forecast to 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; North America

1.3.2&nbsp;&nbsp;&nbsp; Europe

1.3.3&nbsp;&nbsp;&nbsp; Asia Pacific

1.3.4&nbsp;&nbsp;&nbsp; Latin America

1.3.5&nbsp;&nbsp;&nbsp; MEA

1.4&nbsp;&nbsp;&nbsp; Forecast calculations

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Secondary

1.7.1.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.1.2&nbsp;&nbsp;&nbsp;Unpaid sources

1.7.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Tissue diagnostics industry 3600&nbsp;synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Product trends

2.1.4&nbsp;&nbsp;&nbsp; Technology trends

2.1.5&nbsp;&nbsp;&nbsp; Application trends

2.1.6&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Tissue Diagnostics Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rising prevalence of cancer globally

3.2.1.2&nbsp;&nbsp;&nbsp;Growth of personalized therapeutics and diagnostics

3.2.1.3&nbsp;&nbsp;&nbsp;Growing demand for digital pathology

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing number of private diagnostic centers globally

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Lack of skilled professionals

3.2.2.2&nbsp;&nbsp;&nbsp;High cost of diagnosis and reimbursement issues

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By technology

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive landscape

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive dashboard

4.4&nbsp;&nbsp;&nbsp; Company market share, 2022

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.7&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Tissue Diagnostics Market and Forecast, By Product (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Consumables

5.2.1&nbsp;&nbsp;&nbsp; Kits

5.2.2&nbsp;&nbsp;&nbsp; Reagents

5.2.3&nbsp;&nbsp;&nbsp; Antibodies

5.2.4&nbsp;&nbsp;&nbsp; Probes

5.3&nbsp;&nbsp;&nbsp; Instruments

5.3.1&nbsp;&nbsp;&nbsp; Scanners

5.3.2&nbsp;&nbsp;&nbsp; Tissue Processing Systems

5.3.3&nbsp;&nbsp;&nbsp; Slide staining systems

5.3.4&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;Tissue Diagnostics Market and Forecast, By Technology (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by technology

6.2&nbsp;&nbsp;&nbsp; Immunohistochemistry (IHC)

6.3&nbsp;&nbsp;&nbsp; In-situ hybridization (ISH)

6.4&nbsp;&nbsp;&nbsp; Special staining

6.5&nbsp;&nbsp;&nbsp; Digital pathology

6.6&nbsp;&nbsp;&nbsp; Management

Chapter 7&nbsp;&nbsp;&nbsp;Tissue Diagnostics Market Size and Forecast, By Application (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by application

7.2&nbsp;&nbsp;&nbsp; Breast cancer

7.3&nbsp;&nbsp;&nbsp; Prostate cancer

7.4&nbsp;&nbsp;&nbsp; Lung cancer

7.5&nbsp;&nbsp;&nbsp; Lymphoma

7.6&nbsp;&nbsp;&nbsp; Gastric cancer

7.7&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;Tissue Diagnostics Market Size and Forecast, By End-use (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Research laboratories

8.4&nbsp;&nbsp;&nbsp; Pharmaceutical companies

8.5&nbsp;&nbsp;&nbsp; CROs

8.6&nbsp;&nbsp;&nbsp; Others

Chapter 9&nbsp;&nbsp;&nbsp;Tissue diagnostics Market and Forecast, By Region (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key regional trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Poland

9.3.7&nbsp;&nbsp;&nbsp; Switzerland

9.3.8&nbsp;&nbsp;&nbsp; Norway

9.3.9&nbsp;&nbsp;&nbsp; Finland

9.3.10&nbsp;&nbsp;&nbsp; Sweden

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Taiwan

9.4.7&nbsp;&nbsp;&nbsp; Indonesia

9.4.8&nbsp;&nbsp;&nbsp; Vietnam

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Colombia

9.5.5&nbsp;&nbsp;&nbsp; Chile

9.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Israel

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

10.2&nbsp;&nbsp;&nbsp; Abbott Laboratories

10.3&nbsp;&nbsp;&nbsp; Siemens

10.4&nbsp;&nbsp;&nbsp; Danaher

10.5&nbsp;&nbsp;&nbsp; bioM&eacute;rieux SA

10.6&nbsp;&nbsp;&nbsp; QIAGEN

10.7&nbsp;&nbsp;&nbsp; Becton Dickinson &amp; Company

10.8&nbsp;&nbsp;&nbsp; Merck KGaA

10.9&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific, Inc.

10.10&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc

10.11&nbsp;&nbsp;&nbsp; GE Healthcare

10.12&nbsp;&nbsp;&nbsp; BioGenex

10.13&nbsp;&nbsp;&nbsp; Cell Signaling Technology, Inc.

&nbsp;&nbsp;&nbsp;

Tissue Diagnostics Market

Get a free sample of this report